Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Oncol. 2002 May;14(3):318-22.

Chemoprevention of head and neck cancer: an update.

Author information

  • 1Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. vpapadim@mdanderson.org

Abstract

Squamous cell carcinoma of the head and neck is an important public health problem worldwide that is clearly associated with the widely accepted risk factors of tobacco smoking and alcohol use and is the end result of a multiyear, multipath disease process of progressive genetic and associated tissue damage. Chemoprevention, the use of drugs or other agents to inhibit, delay, or reverse this process, is recognized as a very promising and important area in head and neck cancer research. Chemoprevention research is based on the increasing body of knowledge of the biology underlying head and neck tumorigenesis and is expected to ultimately result in a decrease in the incidence of head and neck cancer.

PMID:
11981278
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center